ACVR1 and fibrodysplasia ossificans progressiva: Since then, additional new heterozygous missense causative mutations in ACVR1 have been reported, and further studies indicated that ACVR1R206H mutation occurs in approximately 97% of FOP patients [5, 6] (Fig. 1).